- Home
- BNZI vs MTNB Comparison
BNZI vs MTNB Comparison
Compare BNZI & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- MTNB
- Stock Information
- Founded
- BNZI 2016
- MTNB 2013
- Country
- BNZI United States
- MTNB United States
- Employees
- BNZI N/A
- MTNB N/A
- Industry
- BNZI
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- MTNB Health Care
- Exchange
- BNZI Nasdaq
- MTNB Nasdaq
- Market Cap
- BNZI 11.5M
- MTNB 10.8M
- IPO Year
- BNZI N/A
- MTNB N/A
- Fundamental
- Price
- BNZI $2.21
- MTNB $1.53
- Analyst Decision
- BNZI Strong Buy
- MTNB Hold
- Analyst Count
- BNZI 1
- MTNB 1
- Target Price
- BNZI $30.00
- MTNB N/A
- AVG Volume (30 Days)
- BNZI 482.4K
- MTNB 37.7K
- Earning Date
- BNZI 11-13-2025
- MTNB 11-12-2025
- Dividend Yield
- BNZI N/A
- MTNB N/A
- EPS Growth
- BNZI N/A
- MTNB N/A
- EPS
- BNZI N/A
- MTNB N/A
- Revenue
- BNZI $9,021,543.00
- MTNB N/A
- Revenue This Year
- BNZI $260.63
- MTNB N/A
- Revenue Next Year
- BNZI $35.01
- MTNB N/A
- P/E Ratio
- BNZI N/A
- MTNB N/A
- Revenue Growth
- BNZI 107.94
- MTNB N/A
- 52 Week Low
- BNZI $2.08
- MTNB $0.47
- 52 Week High
- BNZI $28.90
- MTNB $3.35
- Technical
- Relative Strength Index (RSI)
- BNZI 36.91
- MTNB 38.02
- Support Level
- BNZI $2.19
- MTNB $1.82
- Resistance Level
- BNZI $3.13
- MTNB $1.93
- Average True Range (ATR)
- BNZI 0.29
- MTNB 0.13
- MACD
- BNZI -0.11
- MTNB -0.04
- Stochastic Oscillator
- BNZI 1.15
- MTNB 0.50
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.